UK | pharmaphorum

UK

News

Genetic testing company 23andMe is facing a hefty fine from the UK's data protection watchdog for failing to protect its customers' data.

News

UK pharma firms have reacted angrily to the news that the government has doubled the statutory scheme rebate on the sales of newer drugs to the NHS.

News

The NHS is said to be in line for a £30bn increase to its budget in the upcoming spending review, but some are concerned it will not be enough.

News

COVID-19 vaccine tweets from 2020 land Pfizer in trouble for promoting an unlicensed medicine - and reveal the pitfalls of linking content.

News

BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.

News

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead."